Share Facebook Twitter LinkedIn Pinterest Email Sangamo Therapeutics GAAP EPS of $0.04 beats by $0.08, revenue of $49.41M beats by $24.34M
Cleveland-Cliffs could be forced to sell Canadian assets if layoffs proceed, minister warnsOctober 15, 2026
Educational Development outlines 2 main-season and 2 mid-season product intros each year as sales decline narrows to 11% (NASDAQ:EDUC)October 14, 2026